sublingual delivery glp-1 receptor agonists of Human Loaded Nanoliposomal Hydrogel for Treatment of Type 2 Diabetes Mellitus | AAPS PharmSciTech GLP-1 Receptor Agonists for Weight
Description
Garvey WT, Frias JP, Jastreboff AM, et al
Identification of a regulatory pathway of l-phenylalanine-induced GLP-1 secretion in the enteroendocrine L cells
The cardiovascular system and its pathophysiology are complex and GLP-1 asserts its effects through numerous pathways
Patients were initially eligible for surgery if they had a BMI of 40 kg/m 2 or higher, or a BMI between 35 and 40 kg/m 2 with significant comorbidities according to French guidelines [27]
2024 Jun 20;14(6):617
